GBT logo

GBT Retained Earnings

Annual Retained Earnings

-$1.29 B
-$303.09 M-30.72%

December 31, 2021


Summary


Performance

GBT Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Quarterly Retained Earnings

-$1.45 B
-$82.47 M-6.02%

June 30, 2022


Summary


Performance

GBT Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

GBT Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.7%-28.5%
3 y3 years-173.1%-151.3%
5 y5 years-332.8%-537.1%

GBT Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low+12.7%at low
5 y5-year+74.5%at low+96.7%at low
alltimeall time+4497.9%at low+2846.5%at low

Global Blood Therapeutics Retained Earnings History

DateAnnualQuarterly
Jun 2022
-
-$1.45 B(+6.0%)
Mar 2022
-
-$1.37 B(+6.3%)
Dec 2021
-$1.29 B(+30.7%)
-$1.29 B(+7.3%)
Sep 2021
-
-$1.20 B(+6.3%)
Jun 2021
-
-$1.13 B(+6.6%)
Mar 2021
-
-$1.06 B(+7.6%)
Dec 2020
-$986.47 M(+33.5%)
-$986.47 M(+6.7%)
Sep 2020
-
-$924.66 M(+6.9%)
Jun 2020
-
-$864.78 M(+6.5%)
Mar 2020
-
-$811.94 M(+9.9%)
Dec 2019
-$738.92 M(+56.5%)
-$738.92 M(+14.9%)
Sep 2019
-
-$642.94 M(+11.2%)
Jun 2019
-
-$578.39 M(+11.0%)
Mar 2019
-
-$521.07 M(+10.4%)
Dec 2018
-$472.15 M
-$472.15 M(+11.6%)
Sep 2018
-
-$422.95 M(+11.3%)
DateAnnualQuarterly
Jun 2018
-
-$379.88 M(+11.9%)
Mar 2018
-
-$339.51 M(+13.9%)
Dec 2017
-$297.96 M(+64.7%)
-$297.96 M(+16.1%)
Sep 2017
-
-$256.70 M(+12.5%)
Jun 2017
-
-$228.15 M(+11.7%)
Mar 2017
-
-$204.26 M(+12.9%)
Dec 2016
-$180.93 M(+83.8%)
-$180.93 M(+17.7%)
Sep 2016
-
-$153.73 M(+15.8%)
Jun 2016
-
-$132.74 M(+15.4%)
Mar 2016
-
-$115.06 M(+16.9%)
Dec 2015
-$98.47 M(+99.6%)
-$98.47 M(+18.8%)
Sep 2015
-
-$82.88 M(+22.5%)
Jun 2015
-
-$67.68 M(+17.4%)
Mar 2015
-
-$57.65 M(+16.9%)
Dec 2014
-$49.33 M(+75.9%)
-$49.33 M
Dec 2013
-$28.05 M
-

FAQ

  • What is Global Blood Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual retained earnings year-on-year change?
  • What is Global Blood Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly retained earnings year-on-year change?

What is Global Blood Therapeutics annual retained earnings?

The current annual retained earnings of GBT is -$1.29 B

What is the all time high annual retained earnings for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual retained earnings is -$28.05 M

What is Global Blood Therapeutics annual retained earnings year-on-year change?

Over the past year, GBT annual retained earnings has changed by -$303.09 M (-30.72%)

What is Global Blood Therapeutics quarterly retained earnings?

The current quarterly retained earnings of GBT is -$1.45 B

What is the all time high quarterly retained earnings for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly retained earnings is -$49.33 M

What is Global Blood Therapeutics quarterly retained earnings year-on-year change?

Over the past year, GBT quarterly retained earnings has changed by -$322.46 M (-28.51%)